List view / Grid view
Novartis named Brian McNamara to the position of Division Head…
29 February 2012 | By Novartis
Novartis named Brian McNamara to the position of Division Head of Novartis OTC (Over-the-Counter), effective immediately...
Dr. Dimitri Azar elected as new member of the Novartis…
23 February 2012 | By Novartis
Dr. Dimitri Azar elected as new member of the Novartis Board of Directors for a 3yr term...
Novartis is a part of an international effort to eliminate…
30 January 2012 | By Novartis
Novartis is a part of an international effort to eliminate or control 10 NTDs by the end of the decade...
There have been no related adverse events reported with the…
8 January 2012 | By Novartis
There have been no related adverse events reported with the issues leading to the recall...
Discovery of a new class of dual-acting antimalarial compounds...
17 November 2011 | By Novartis
Discovery of a new class of dual-acting antimalarial compounds...
Alcon to accelerate growth through Novartis strength in market access,…
13 September 2011 | By Novartis
Alcon to accelerate growth through Novartis strength in market access, reimbursement, and research capability...
Construction of this facility represents the most significant Novartis investment…
16 June 2011 | By Novartis
Construction of this facility represents the most significant Novartis investment in Russia...
Novartis shareholders followed the Board of Directors' recommendation, approving the…
8 April 2011 | By Novartis
Novartis shareholders followed the Board of Directors' recommendation, approving the proposed merger of Alcon, Inc. into Novartis...
Novartis announced that effective March 2, Naomi Kelman is appointed…
17 February 2011 | By Novartis
Novartis announced that effective March 2, Naomi Kelman is appointed Head of the Novartis OTC Division...
Novartis announced today that it has entered into a definitive…
24 January 2011 | By Novartis
Novartis announced today that it has entered into a definitive agreement for the acquisition of Genoptix, Inc...
Novartis presented a strategic overview of the company's diversified healthcare…
17 November 2010 | By Novartis
Novartis presented a strategic overview of the company's diversified healthcare portfolio which creates potential for future sustainable growth...
